// STATE LEGISLATION TRACKER

Virginia HB 2248: Pharmacy; practice, regulation by Board of Pharmacy.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Virginia
Bill: HB 2248
Filed: 2019-01-08
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Virginia HB2248 was a narrow pharmacy-compounding bill about drugs made for Department of Corrections lethal injections. Based on the available summary, it did not change access to compounded peptides, off-label prescribing, telehealth, NP or naturopathic scope, or routine patient prescriptions.

Key Points

No direct change to compounded peptide access
No change to off-label prescribing rules
No telehealth or NP scope expansion
Targets execution-drug compounding, not patient care
Would limit that narrow compounding work to outsourcing facilities

What to Watch For

Note The bill uses pharmacy-compounding language, but the impact appears limited to Department of Corrections execution drugs.

Note No apparent change to 503A-style patient-specific compounding for peptides.

Note No apparent change to prescription monitoring or controlled-substance prescribing for patients.

Where the Bill Stands

The 2019 bill was introduced but died in the House General Laws Committee on February 5, 2019.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws